# Abcam plc (ABCM)

Source: https://www.quantisnow.com/company/ABCM
Generated: 2026-11-09T18:34:14.709Z

- Ticker: ABCM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2020
- Website: abcam.com

## About

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

## Latest ABCM news and filings

- 2024-02-12 22:24 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-abcam-plc-amendment-5251285)
- 2024-01-12 16:40 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-abcam-plc-amendment-5185572)
- 2023-12-18 21:17 UTC [SEC Form 15-12G filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-abcam-plc-5143652)
- 2023-12-15 21:24 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abcam-plc-5140894)
- 2023-12-15 21:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abcam-plc-5140864)
- 2023-12-15 21:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-abcam-plc-5140836)
- 2023-12-15 21:16 UTC [SEC Form POSASR filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-abcam-plc-5140805)
- 2023-12-08 21:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5127828)
- 2023-12-06 14:00 UTC [SEC Form 25-NSE filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-abcam-plc-5121737)
- 2023-12-06 12:30 UTC [Danaher Completes Acquisition of Abcam](https://www.quantisnow.com/insight/danaher-completes-acquisition-of-abcam-5121258)
- 2023-12-06 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5121151)
- 2023-12-04 21:02 UTC [Market Chatter] [Acquisition Of Abcam By Danaher For $24.00 Per Share In Cash Approved By The High Court Of Justice Of England And Wales](https://www.quantisnow.com/insight/acquisition-of-abcam-by-danaher-for-2400-per-share-in-5116443)
- 2023-12-04 21:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5116436)
- 2023-12-04 21:01 UTC [Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales](https://www.quantisnow.com/insight/acquisition-of-abcam-by-danaher-approved-by-the-high-court-5116420)
- 2023-11-20 20:38 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5095835)
- 2023-11-20 13:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5094976)
- 2023-11-17 12:16 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5091832)
- 2023-11-17 12:08 UTC [Market Chatter] [Abcam Has Obtained All Clearances Required In Connection With Proposed Acquisition By Danaher For $24.00 Per Share In Cash](https://www.quantisnow.com/insight/abcam-has-obtained-all-clearances-required-in-connection-with-proposed-5091816)
- 2023-11-17 12:00 UTC [Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023](https://www.quantisnow.com/insight/abcam-acquisition-by-danaher-has-received-all-identified-clearances-transaction-5091781)
- 2023-11-06 21:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5061959)
- 2023-11-06 21:01 UTC [Market Chatter] [Abcam Shareholders Approve Proposed Acquisition By Danaher](https://www.quantisnow.com/insight/abcam-shareholders-approve-proposed-acquisition-by-danaher-5061925)
- 2023-11-06 21:00 UTC [Shareholders of Abcam Approve Proposed Acquisition by Danaher](https://www.quantisnow.com/insight/shareholders-of-abcam-approve-proposed-acquisition-by-danaher-5061893)
- 2023-11-01 11:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5048849)
- 2023-11-01 11:00 UTC [Statement from Dr. Jonathan Milner on the suspension of the "Vote AGAINST" campaign](https://www.quantisnow.com/insight/statement-from-dr-jonathan-milner-on-the-suspension-of-the-5048622)
- 2023-10-31 13:57 UTC [Market Chatter] [RBC Capital Maintains Sector Perform on Abcam, Lowers Price Target to $24](https://www.quantisnow.com/insight/rbc-capital-maintains-sector-perform-on-abcam-lowers-price-target-5046316)
- 2023-10-23 11:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5031701)
- 2023-10-23 11:30 UTC [Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcam](https://www.quantisnow.com/insight/leading-independent-proxy-advisor-glass-lewis-joins-iss-in-recommending-5031689)
- 2023-10-23 11:10 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5031632)
- 2023-10-23 06:57 UTC [Market Chatter] [Jonathan Milner Welcomes Glass Lewis Report Insights, Urges Shareholders To Reject Abcam's Sale To Danaher](https://www.quantisnow.com/insight/jonathan-milner-welcomes-glass-lewis-report-insights-urges-shareholders-to-5031332)
- 2023-10-23 06:00 UTC [Jonathan Milner Issues Statement Responding to the Glass Lewis Report](https://www.quantisnow.com/insight/jonathan-milner-issues-statement-responding-to-the-glass-lewis-report-5031326)
- 2023-10-17 11:32 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5022920)
- 2023-10-17 11:30 UTC [Leading Proxy Advisor, ISS, Recommends Shareholders Vote "FOR" Danaher Corporation's Proposed Acquisition of Abcam](https://www.quantisnow.com/insight/leading-proxy-advisor-iss-recommends-shareholders-vote-for-danaher-corporations-5022907)
- 2023-10-16 20:00 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5021872)
- 2023-10-16 17:12 UTC [Jonathan Milner Issues Statement Responding to ISS Report](https://www.quantisnow.com/insight/jonathan-milner-issues-statement-responding-to-iss-report-5021625)
- 2023-10-16 14:34 UTC [Market Chatter] [Jonathan Milner Releases Presentation To Abcam Shareholders, Outlining Reasons To Reject Danaher's Bid And Strategic Vision For The Company](https://www.quantisnow.com/insight/jonathan-milner-releases-presentation-to-abcam-shareholders-outlining-reasons-to-5021327)
- 2023-10-16 14:22 UTC [Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher's bid and strategic vision for the Company](https://www.quantisnow.com/insight/jonathan-milner-releases-presentation-to-abcam-plc-shareholders-outlining-reasons-5021303)
- 2023-10-16 12:00 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-abcam-plc-5020770)
- 2023-10-12 11:46 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Abcam plc (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-abcam-plc-amendment-5016409)
- 2023-10-12 11:30 UTC [SEC Form 6-K] [SEC Form 6-K filed by Abcam plc](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-abcam-plc-5016352)
- 2023-10-12 11:30 UTC [Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher](https://www.quantisnow.com/insight/independent-directors-of-abcam-highlight-compelling-reasons-for-shareholders-to-5016343)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ABCM
- Earnings history: https://www.quantisnow.com/earnings/ABCM
- Dividend history: https://www.quantisnow.com/dividends/ABCM
- Insider transactions: https://www.quantisnow.com/insiders/ABCM
- Options chain: https://www.quantisnow.com/options/ABCM
- SEC 8-K filings only: https://www.quantisnow.com/company/ABCM/8-k
- RSS and alerts for ABCM: https://www.quantisnow.com/docs/rss-feeds.md